Chamberlain NR 565 Advanced Pharmacology Fundamentals
Final Exam | 200 Practice Questions & Detailed Answers |
2026/2027 | A+ Graded
1. A patient asks how a medication taken by mouth produces an effect in the body. The APRN explains
that the process by which a drug is absorbed, distributed, metabolized, and excre ted is known as:
A) Pharmacodynamics
B) Pharmacotherapeutics
C) Pharmacokinetics
D) Pharmacogenomics
Answer: C – Pharmacokinetics is the study of drug movement throughout the body, including
absorption, distribution, metabolism, and excretion (ADME). Pharmacodynamics is what the drug does
to the body.
2. A drug that binds to a receptor and produces a response that is less than that of a full agonist, even at
maximal concentrations, is known as a:
A) Partial agonist
B) Inverse agonist
C) Competitive antagonist
D) Noncompetitive antagonist
Answer: A – A partial agonist has lower efficacy than a full agonist. It binds to and activates a receptor
but cannot produce a maximal response, even when all receptors are occupied.
,3. An APRN is prescribing a medication that is known to be a CYP450 enzyme inducer. What effect will
this have on other medications metabolized by that enzyme pathway?
A) Increased serum levels of the other medications, potentially leading to toxicity
B) Decreased serum levels of the other medications, potentially leading to therapeutic failure
C) No effect on serum levels of the other medications
D) Prolonged halflife of the other medications
Answer: B – CYP450 inducers increase the metabolic activity of liver enzymes, leading to faster
breakdown of medications metabolized through that pathway. This results in decreased serum
concentrations and potential loss of therapeutic effect.
4. Which organ is the primary site for drug metabolism?
A) Kidneys
B) Liver
C) Lungs
D) Spleen
Answer: B – The liver contains the cytochrome P450 enzyme system essential for drug metabolism. The
kidneys are the main organs for drug excretion. The lungs excrete volatile gases but are not the primary
site of metabolism.
5. What does the term "bioavailability" refer to in pharmacokinetics?
,A) The amount of drug excreted in the urine
B) The percentage of an administered dose of unchanged drug that reaches the systemic circulation
C) The halflife of the drug in the body
D) The volume of fluid into which the drug distributes
Answer: B – Bioavailability measures the extent and rate of drug entry into systemic circulation. Renal
clearance refers to drug excretion. Halflife is the time for drug concentration to decrease by half.
6. A drug that binds to a receptor and produces a biological response is called a(n):
A) Antagonist
B) Agonist
C) Partial agonist
D) Inverse agonist
Answer: B – An agonist binds to a receptor and activates it to produce a biological response. An
antagonist binds but blocks the response. A partial agonist produces a weaker response than a full
agonist.
7. The time required for the plasma concentration of a drug to decrease by 50% is called:
A) Onset of action
B) Duration of action
C) Halflife
D) Bioavailability
, Answer: C – Halflife is the time required for the plasma concentration of a drug to decrease by 50%.
Onset of action is the time to therapeutic effect. Duration is how long the effect lasts.
8. The therapeutic index (TI) is defined as:
A) The ratio of toxic dose to therapeutic dose
B) The ratio of therapeutic dose to toxic dose
C) The dose required to produce a therapeutic effect
D) The dose required to produce a toxic effect
Answer: A – The therapeutic index (TI) is the ratio of the toxic dose to the therapeutic dose (LD50/ED50).
A high TI indicates a safe drug; a low TI indicates a drug with a narrow margin of safety.
9. A drug that binds to a receptor but does NOT produce a response is called:
A) Agonist
B) Partial agonist
C) Antagonist
D) Inverse agonist
Answer: C – An antagonist binds to a receptor and blocks the response. An agonist produces a response.
A partial agonist produces a submaximal response.
Final Exam | 200 Practice Questions & Detailed Answers |
2026/2027 | A+ Graded
1. A patient asks how a medication taken by mouth produces an effect in the body. The APRN explains
that the process by which a drug is absorbed, distributed, metabolized, and excre ted is known as:
A) Pharmacodynamics
B) Pharmacotherapeutics
C) Pharmacokinetics
D) Pharmacogenomics
Answer: C – Pharmacokinetics is the study of drug movement throughout the body, including
absorption, distribution, metabolism, and excretion (ADME). Pharmacodynamics is what the drug does
to the body.
2. A drug that binds to a receptor and produces a response that is less than that of a full agonist, even at
maximal concentrations, is known as a:
A) Partial agonist
B) Inverse agonist
C) Competitive antagonist
D) Noncompetitive antagonist
Answer: A – A partial agonist has lower efficacy than a full agonist. It binds to and activates a receptor
but cannot produce a maximal response, even when all receptors are occupied.
,3. An APRN is prescribing a medication that is known to be a CYP450 enzyme inducer. What effect will
this have on other medications metabolized by that enzyme pathway?
A) Increased serum levels of the other medications, potentially leading to toxicity
B) Decreased serum levels of the other medications, potentially leading to therapeutic failure
C) No effect on serum levels of the other medications
D) Prolonged halflife of the other medications
Answer: B – CYP450 inducers increase the metabolic activity of liver enzymes, leading to faster
breakdown of medications metabolized through that pathway. This results in decreased serum
concentrations and potential loss of therapeutic effect.
4. Which organ is the primary site for drug metabolism?
A) Kidneys
B) Liver
C) Lungs
D) Spleen
Answer: B – The liver contains the cytochrome P450 enzyme system essential for drug metabolism. The
kidneys are the main organs for drug excretion. The lungs excrete volatile gases but are not the primary
site of metabolism.
5. What does the term "bioavailability" refer to in pharmacokinetics?
,A) The amount of drug excreted in the urine
B) The percentage of an administered dose of unchanged drug that reaches the systemic circulation
C) The halflife of the drug in the body
D) The volume of fluid into which the drug distributes
Answer: B – Bioavailability measures the extent and rate of drug entry into systemic circulation. Renal
clearance refers to drug excretion. Halflife is the time for drug concentration to decrease by half.
6. A drug that binds to a receptor and produces a biological response is called a(n):
A) Antagonist
B) Agonist
C) Partial agonist
D) Inverse agonist
Answer: B – An agonist binds to a receptor and activates it to produce a biological response. An
antagonist binds but blocks the response. A partial agonist produces a weaker response than a full
agonist.
7. The time required for the plasma concentration of a drug to decrease by 50% is called:
A) Onset of action
B) Duration of action
C) Halflife
D) Bioavailability
, Answer: C – Halflife is the time required for the plasma concentration of a drug to decrease by 50%.
Onset of action is the time to therapeutic effect. Duration is how long the effect lasts.
8. The therapeutic index (TI) is defined as:
A) The ratio of toxic dose to therapeutic dose
B) The ratio of therapeutic dose to toxic dose
C) The dose required to produce a therapeutic effect
D) The dose required to produce a toxic effect
Answer: A – The therapeutic index (TI) is the ratio of the toxic dose to the therapeutic dose (LD50/ED50).
A high TI indicates a safe drug; a low TI indicates a drug with a narrow margin of safety.
9. A drug that binds to a receptor but does NOT produce a response is called:
A) Agonist
B) Partial agonist
C) Antagonist
D) Inverse agonist
Answer: C – An antagonist binds to a receptor and blocks the response. An agonist produces a response.
A partial agonist produces a submaximal response.
